Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (342)	12/1/1998 11:24:00 PM
From: Bill Rogers	Respond to of 534

Spoke with bio-medical guy from 3M over the holidays. This patch thing is going to be big but it is taking alot of dollars and research to get the patch to deliver the dosage right, everyone will absorb differently they are finding do bio-jet still has alot of time to do its thing IMHO.

To: geewiz who wrote (342)	12/3/1998 11:41:00 AM
From: GREG FINLEY	Respond to of 534

Hi Geewiz, Elan has many partnerships such as this. It was explained to me that they form these partnerships to avoid very strict taxation in Ireland. The deal they have with BJCT is in no way compromised by this Endorex announcement. Hope this helps... Always, Greg